跳至主要内容
临床试验/NCT00839319
NCT00839319已完成1 期

Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3)

University of Washington1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
59
试验地点
1
主要终点
Serum Testosterone (T)

研究概览

简要总结

The purpose of this investigational study is to determine how much male hormone, testosterone, is necessary to maintain sperm production in the testis. This knowledge will be used to help in the development of a safe male hormonal contraception.

详细描述

Three study drugs will be used in this study: Testim (testosterone gel), Human Chorionic Gonadotropin (hCG) and acyline. Testosterone is a naturally occurring hormone in men. When given to normal men, testosterone gel will temporarily lower the amount of testosterone in the testes and lower sperm counts. hCG is a female hormone produced during pregnancy that is similar to and has the same actions as a male hormone, luteinizing hormone (LH). Like LH, hCG stimulates the testis to produce testosterone and sperm, and is used in the treatment of men who are deficient in LH. When hCG is given together with testosterone to normal men, the amount of testosterone in the testes will change, dependent on the amount of hCG received. Some participants will receive placebo hCG injections (no active medication).

Acyline suppresses LH (luteinizing hormone) and FSH (follicle stimulating hormone), which are hormones made by the pituitary gland in the brain, thus blocking the signal from the brain that causes the testes to make testosterone. Therefore, acyline blocks testosterone production. Men may experience some side effects from the low levels of testosterone caused by acyline.

Acyline is an experimental drug. Testosterone gel and hCG are approved for use in men with low testosterone levels. The U.S. Food and Drug Administration (FDA) allows testosterone gel, hCG and acyline to be given in combination for research to a small number of volunteers. Over 125 men have received acyline. Both Acyline and hCG will be given by injection. Acyline injections are formulated by subjects weight and may be given in multiple injections.

Participation will last approximately 2 months. The study involves a minimum of 9 visits in Seattle, WA. Clinic visits at Screening, Day 1 and Day 10 will take about 1-1.5 hours each. On Day 1 & 10 a fine needle aspiration of one testis will be performed. The Day 7, Day 17, and Day 40 visits will take approximately 30 minutes. The other visits will take about 15 minutes each time. Over the course of the study, which includes 5 separate blood draws, approximately 12 ounces (one and a half cups) of blood will be drawn. Some of the study drugs will be given by injection. One drug is a topical gel.

This is NOT a trial of a male contraceptive, and the study medications will not prevent pregnancy. Subjects must use an acceptable form of birth control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Males age 18-50
  • Normal serum testosterone, LH and FSH
  • PSA < 4.0
  • Agrees not to donate blood or participate in another research study during the study
  • Informed consent
  • In general good health based on normal screening evaluation (consisting of a medical history, physical exam, normal sperm count, normal serum chemistry and hematology)
  • Must be willing to use a reliable form of contraception during the study

排除标准

  • Oligospermia (sperm count < 15 million/mL after 48 hours of abstinence) and/or abnormal motility or morphology.
  • Participation in a long-term male contraceptive study within the past three months
  • History of testosterone or anabolic steroid abuse in the past
  • Poor general health with significantly abnormal blood results
  • History of or current testicular disease
  • History of a bleeding disorder or need for anticoagulation
  • History of sleep apnea and/or major psychiatric problems
  • BMI > 32
  • Subjects with a skin condition that might interfere or be exacerbated by testosterone gel use
  • Subject's with alcohol or drug use

研究组 & 干预措施

Acyline plus 125 IU hCG

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus subcutaneous 125 IU hCG injection (inj) every other day (5 doses) for 10 days

干预措施: Acyline (Drug)

Acyline plus Placebo

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus subcutaneous placebo hCG injection (inj) every other day (5 doses) for 10 days

干预措施: Acyline (Drug)

Acyline plus Placebo

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus subcutaneous placebo hCG injection (inj) every other day (5 doses) for 10 days

干预措施: placebo hCG (no active ingredient) (Other)

Acyline plus 15 IU hCG

Experimental

Acyline 300 ug/kg (SQ) inj(s) on Day 1 plus subcutaneous 15 IU hCG injection (inj) every other day (5 doses) for 10 days

干预措施: Acyline (Drug)

Acyline plus 15 IU hCG

Experimental

Acyline 300 ug/kg (SQ) inj(s) on Day 1 plus subcutaneous 15 IU hCG injection (inj) every other day (5 doses) for 10 days

干预措施: hCG (human chorionic gonadotropin) (Drug)

Acyline plus 60 IU hCG

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus subcutaneous 60 IU hCG injection (inj) every other day (5 doses) for 10 days

干预措施: Acyline (Drug)

Acyline plus 60 IU hCG

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus subcutaneous 60 IU hCG injection (inj) every other day (5 doses) for 10 days

干预措施: hCG (human chorionic gonadotropin) (Drug)

Acyline plus 125 IU hCG

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus subcutaneous 125 IU hCG injection (inj) every other day (5 doses) for 10 days

干预措施: hCG (human chorionic gonadotropin) (Drug)

Acyline plus Testosterone gel

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus Testosterone gel 75 mg/day daily for 10 days

干预措施: Acyline (Drug)

Acyline plus Testosterone gel

Experimental

Acyline 300 ug/kg subcutaneous (SQ) injections on Day 1 plus Testosterone gel 75 mg/day daily for 10 days

干预措施: Testosterone gel (Drug)

结局指标

主要结局

Serum Testosterone (T)

时间窗: 10 days

Serum Luteinizing Hormone (LH)

时间窗: 10 days

Serum Follicle Stimulating Hormone (FSH)

时间窗: 10 days

Intratesticular Testosterone (ITT-T)

时间窗: 10 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John Amory

Professor, Department of Medicine

University of Washington

研究点 (1)

Loading locations...

相似试验